150 related articles for article (PubMed ID: 18335586)
21. [Does the public sector have an independent research role in the development of drugs?].
Poulsen HE; Grønlykke TB
Ugeskr Laeger; 2003 Apr; 165(16):1674-6. PubMed ID: 12756828
[TBL] [Abstract][Full Text] [Related]
22. Sharing the burden of TB/HIV? Costs and financing of public-private partnerships for tuberculosis treatment in South Africa.
Sinanovic E; Kumaranayake L
Trop Med Int Health; 2006 Sep; 11(9):1466-74. PubMed ID: 16930269
[TBL] [Abstract][Full Text] [Related]
23. Associations say no to industry funding.
Kuehn BM
JAMA; 2009 May; 301(18):1865-6. PubMed ID: 19436005
[No Abstract] [Full Text] [Related]
24. Chancellor unveils "son of PFI" to build next generation of hospitals.
Torjesen I
BMJ; 2012 Dec; 345():e8334. PubMed ID: 23220385
[No Abstract] [Full Text] [Related]
25. The BetterCare judgment--a challenge to health care.
Pollock AM; Price D
BMJ; 2003 Feb; 326(7383):236-7. PubMed ID: 12560253
[No Abstract] [Full Text] [Related]
26. Can public financing of the private sector defeat antimicrobial resistance?
James JE
J Public Health (Oxf); 2019 Jun; 41(2):422-426. PubMed ID: 29982521
[TBL] [Abstract][Full Text] [Related]
27. Public-private partnerships: an overview.
Widdus R
Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S1-8. PubMed ID: 16085172
[TBL] [Abstract][Full Text] [Related]
28. A lifeline for the biotech sector.
Kessel M
Nat Biotechnol; 2009 Feb; 27(2):123-4. PubMed ID: 19204686
[No Abstract] [Full Text] [Related]
29. Public-private partnerships in health care for developing countries: a new paradigm for change.
Ahn M; Herman A; Damonti J
Manag Care Q; 2000; 8(4):65-72. PubMed ID: 11146847
[TBL] [Abstract][Full Text] [Related]
30. Financing long-term care: how much public? How much private?
Wiener JM; Hanley RJ; Illston LH
J Health Polit Policy Law; 1992; 17(3):425-34. PubMed ID: 1464706
[No Abstract] [Full Text] [Related]
31. New tools for an old disease.
Garwood P
Bull World Health Organ; 2007 May; 85(5):331-2. PubMed ID: 17639213
[No Abstract] [Full Text] [Related]
32. Private health sector in India: is private health care at the cost of public health care?
Bose A
BMJ; 2005 Dec; 331(7528):1338-9. PubMed ID: 16322030
[No Abstract] [Full Text] [Related]
33. Review of US medical school finances, 1993-1994.
Ganem JL; Beran RL; Krakower JK
JAMA; 1995 Sep; 274(9):723-30. PubMed ID: 7650826
[No Abstract] [Full Text] [Related]
34. Biotech's wellspring--a survey of the health of the private sector in 2014.
Huggett B
Nat Biotechnol; 2015 May; 33(5):470-7. PubMed ID: 25965753
[No Abstract] [Full Text] [Related]
35. Pharmacoeconomics in the years of crisis: a solution or just a resolution? A Cyprus perspective.
Petrou P
Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):627-36. PubMed ID: 24953125
[TBL] [Abstract][Full Text] [Related]
36. A new era of hope for the world's most neglected diseases.
The
PLoS Med; 2005 Sep; 2(9):e323. PubMed ID: 16138790
[TBL] [Abstract][Full Text] [Related]
37. How to make global trade diminish poverty.
Lancet; 2002 Apr; 359(9315):1359. PubMed ID: 11978326
[No Abstract] [Full Text] [Related]
38. Private investment in AIDS vaccine development: obstacles and solutions.
Batson A; Ainsworth M
Bull World Health Organ; 2001; 79(8):721-7. PubMed ID: 11545328
[TBL] [Abstract][Full Text] [Related]
39. Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006.
Houston JG; Banks MN; Binnie A; Brenner S; O'Connell J; Petrillo EW
Drug Discov Today; 2008 Jan; 13(1-2):44-51. PubMed ID: 18190863
[TBL] [Abstract][Full Text] [Related]
40. Public-private partnership: from there to here.
Croft SL
Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S9-14. PubMed ID: 16087204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]